C10orf55
Basic information
Region (hg38): 10:73908103-73922810
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Quebec platelet disorder (69 variants)
- not provided (20 variants)
- Inborn genetic diseases (13 variants)
- Alzheimer disease, late-onset, susceptibility to (1 variants)
- PLAU-related condition (1 variants)
- Hirschsprung disease, susceptibility to, 1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C10orf55 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 0 | |||||
non coding | 40 | 10 | 38 | 88 | ||
Total | 0 | 0 | 40 | 11 | 40 |
Variants in C10orf55
This is a list of pathogenic ClinVar variants found in the C10orf55 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-73911209-G-A | Quebec platelet disorder | Uncertain significance (Jan 13, 2018) | ||
10-73911218-G-A | Quebec platelet disorder | Uncertain significance (Jan 13, 2018) | ||
10-73911227-C-G | Quebec platelet disorder | Uncertain significance (Jan 13, 2018) | ||
10-73911404-G-T | Benign (Jun 19, 2021) | |||
10-73911531-C-T | Quebec platelet disorder | Benign/Likely benign (Oct 01, 2023) | ||
10-73911536-A-G | Quebec platelet disorder | Benign (Jan 12, 2018) | ||
10-73911538-C-A | Quebec platelet disorder | Benign (Jan 12, 2018) | ||
10-73911572-C-A | Quebec platelet disorder • not specified | Conflicting classifications of pathogenicity (Sep 29, 2022) | ||
10-73911598-G-T | Quebec platelet disorder | Benign (Jan 12, 2018) | ||
10-73911618-T-C | Quebec platelet disorder | Likely benign (Jan 12, 2018) | ||
10-73912117-G-A | Benign (Jun 19, 2021) | |||
10-73912216-G-T | C10orf55-related disorder | Likely benign (May 17, 2021) | ||
10-73912227-G-C | PLAU-related disorder | Uncertain significance (Sep 16, 2024) | ||
10-73912240-A-G | Quebec platelet disorder | Benign (May 22, 2017) | ||
10-73912272-T-A | Quebec platelet disorder | Uncertain significance (Jan 12, 2018) | ||
10-73912291-A-G | Quebec platelet disorder • PLAU-related disorder | Benign/Likely benign (Mar 01, 2023) | ||
10-73912292-A-G | Quebec platelet disorder • PLAU-related disorder | Benign (Jan 13, 2018) | ||
10-73912301-G-A | Hirschsprung disease, susceptibility to, 1 • Quebec platelet disorder | Benign/Likely benign (Jun 01, 2024) | ||
10-73912319-A-T | not specified | Uncertain significance (Jan 06, 2023) | ||
10-73912619-G-GT | Benign (Jun 19, 2021) | |||
10-73912620-G-T | Benign (Jun 19, 2021) | |||
10-73912717-A-G | Benign (Jun 19, 2021) | |||
10-73912917-C-G | C10orf55-related disorder | Likely benign (May 31, 2023) | ||
10-73912924-A-G | Quebec platelet disorder | Uncertain significance (Jan 12, 2018) | ||
10-73912966-G-A | Quebec platelet disorder | Benign (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C10orf55 | protein_coding | protein_coding | ENST00000409178 | 2 | 12809 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0144 | 0.461 | 125717 | 0 | 3 | 125720 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.423 | 74 | 85.0 | 0.871 | 0.00000411 | 966 |
Missense in Polyphen | 7 | 12.58 | 0.55642 | 117 | ||
Synonymous | 1.38 | 24 | 34.3 | 0.699 | 0.00000184 | 328 |
Loss of Function | -0.801 | 2 | 1.10 | 1.83 | 4.66e-8 | 12 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.584
- rvis_EVS
- 0.68
- rvis_percentile_EVS
- 84.81
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.146
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |